Odylia is a unique nonprofit biotech bringing life-changing treatments to people with rare genetic disorders, regardless of prevalence or commercial interest. We help groups navigate the complexity of bringing treatments from the lab to patients.
Can you imagine new treatments being developed hand-in-hand with patients, families, researchers, and companies? We build innovative partnerships and unique solutions that involve rare disease patients in the process of making new therapeutics.
There is little commercial interest in these treatments due to the rare nature of the diseases. Odylia relies on contributions from nonprofit organizations, patient groups, corporate donors, and more to help advance our mission of bringing life-changing treatments to people with rare disease.